Skip to main content
. 2020 Dec 22;13(1):3. doi: 10.3390/cancers13010003

Table 4.

Association between predictive factors and overall survival of CRC in the validation cohort.

Demographic or Characteristic Univariate Analysis Multivariate Analysis
HR (95% CI) p Value HR (95% CI) p Value
Age <0.001 <0.001
<60 1.000 1.000
≥60 1.418 (1.197–1.679) 1.468 (1.235–1.745)
Gender 0.508 0.604
Male 1.000 1.000
Female 1.059 (0.893–1.256) 1.047 (0.881–1.244)
Tumor location 0.397 0.653
Colon 1.000 1.000
Rectum 0.930 (0.786–1.100) 0.958 (0.793–1.156)
Tumor diameter 0.603 0.288
<50 mm 1.000 1.000
≥50 mm 1.048 (0.878–1.252) 1.106 (0.919–1.331)
Pathological classification
Prominence 1.000 1.000
Infiltration or Ulceration 1.488 (1.189–1.861) 0.001 1.223 (0.972–1.539) 0.086
Infiltration and Ulceration 1.616 (1.081–2.415) 0.019 1.424 (0.948–2.139) 0.088
Differentiation degree
Well 1.000 1.000
Moderate 2.289 (0.570–9.196) 0.243 1.350 (0.334–5.452) 0.673
Poor 4.904 (1.218–19.745) 0.025 2.096 (0.516–8.513) 0.301
Histologic classification 0.001 0.634
Adenocarcinoma 1.000 1.000
Mucinous adenocarcinoma or signet ring cell carcinoma 1.413 (1.145–1.743) 1.059 (0.838–1.338)
TNM staging <0.001 <0.001
II 1.000 1.000
III 2.985 (2.414–3.691) 2.083 (1.648–2.634)
Nerve invasion <0.001 0.010
No 1.000 1.000
Yes 1.950 (1.635–2.325) 1.284 (1.062–1.551)
Vascular tumor thrombus <0.001 <0.001
No 1.000 1.000
Yes 2.774 (2.342–3.285) 1.721 (1.427–2.076)
CEA <0.001 <0.001
<5 ng/mL 1.000 1.000
≥5 ng/mL 2.375 (1.994–2.830) 1.661 (1.376–2.006)
CA19-9 <0.001 <0.001
<37 U/mL 1.000 1.000
≥37 U/mL 3.073 (2.583–3.654) 1.917 (1.581–2.323)
Postoperative chemotherapy 0.014 <0.001
No 1.000 1.000
Yes 0.774 (0.631–0.949) 0.618 (0.499–0.766)
Postoperative radiotherapy 0.016 0.089
No 1.000 1.000
Yes 1.329 (1.055–1.675) 1.257 (0.965–1.637)
OS-PII (Continuous) 1.164 (1.107–1.224) <0.001 1.133 (1.076–1.194) <0.001
OS-PII (Binary) <0.001 <0.001
≤4.27 1.000 1.000
>4.27 1.561 (1.316–1.852) 1.407 (1.182–1.674)

Abbreviations: HR, hazard ratio; CI, confidence interval.